Cao Xie

4.4k total citations
92 papers, 3.7k citations indexed

About

Cao Xie is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Cao Xie has authored 92 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 36 papers in Biomaterials and 19 papers in Biomedical Engineering. Recurrent topics in Cao Xie's work include RNA Interference and Gene Delivery (41 papers), Nanoparticle-Based Drug Delivery (33 papers) and Advanced biosensing and bioanalysis techniques (19 papers). Cao Xie is often cited by papers focused on RNA Interference and Gene Delivery (41 papers), Nanoparticle-Based Drug Delivery (33 papers) and Advanced biosensing and bioanalysis techniques (19 papers). Cao Xie collaborates with scholars based in China, South Korea and United States. Cao Xie's co-authors include Weiyue Lu, Changyou Zhan, Xiaoli Wei, Yu Liu, Bing Gu, Zhiqiang Yan, Jie Gao, Danni Ran, Ying Man and Jin Li and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nano Letters.

In The Last Decade

Cao Xie

90 papers receiving 3.7k citations

Peers

Cao Xie

BIOMA

ONCOL

IMMUN

Hongliang Xin China

Liang Han China

Tanyel Kiziltepe United States

Jiangbing Zhou United States

Zhiqiang Yan China

Ting Kang China

Marcel H.A.M. Fens Netherlands

In-San Kim South Korea

Chen Jiang China

Hyejung Mok South Korea

Hongliang Xin China

Cao Xie

1.6k ×0.8

1.8k ×1.1

BIOMA

1.5k ×1.2

381 ×1.0

ONCOL

441 ×1.3

IMMUN

Citations per year, relative to Cao Xie Cao Xie (= 1×) peers Hongliang Xin

Countries citing papers authored by Cao Xie

Since Specialization

Citations

This map shows the geographic impact of Cao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cao Xie more than expected).

Fields of papers citing papers by Cao Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cao Xie. The network helps show where Cao Xie may publish in the future.

Co-authorship network of co-authors of Cao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Cao Xie. A scholar is included among the top collaborators of Cao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cao Xie. Cao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meng, Nana, Jiasheng Lu, Jianfen Zhou, et al.. (2025). Improved immunocompatibility of active targeting liposomes by attenuating nucleophilic attack of cyclic RGD peptides on complement 3. Biomaterials. 321. 123350–123350. 5 indexed citations

Zhou, Jianfen, Nana Meng, Linwei Lu, et al.. (2024). A novel peptide-drug conjugate for glioma-targeted drug delivery. Journal of Controlled Release. 369. 722–733. 12 indexed citations

Wang, Xiaoshuang, Yan Zhou, Cao Xie, et al.. (2024). Single-cell transcriptomics reveals the role of antigen presentation in liver metastatic breast cancer. iScience. 27(2). 108896–108896. 7 indexed citations

Luo, Zimiao, Jianfen Zhou, Linwei Lu, et al.. (2022). All-stage targeted therapy for the brain metastasis from triple-negative breast cancer. Acta Pharmaceutica Sinica B. 13(1). 359–371. 16 indexed citations

Feng, Mei, Yan Zhou, Shenglin Mei, et al.. (2021). BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer. Signal Transduction and Targeted Therapy. 6(1). 313–313. 28 indexed citations

Zhang, Qiao, Xiaomin Guo, Cao Xie, et al.. (2021). Unraveling the metabolic pathway of choline-TMA-TMAO: Effects of gypenosides and implications for the therapy of TMAO related diseases. Pharmacological Research. 173. 105884–105884. 25 indexed citations

Wang, Songli, Ruifeng Wang, Nana Meng, et al.. (2020). Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy. Journal of Controlled Release. 328. 78–86. 60 indexed citations

Wang, Huan, Songli Wang, Ruifeng Wang, et al.. (2019). Co-delivery of paclitaxel and melittin by glycopeptide-modified lipodisks for synergistic anti-glioma therapy. Nanoscale. 11(27). 13069–13077. 38 indexed citations

Ruan, Huitong, Zhilan Chai, Qing Shen, et al.. (2018). A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery. Journal of Controlled Release. 279. 306–315. 67 indexed citations

10.

Chen, Xishan, Lingyu Tai, Jie Gao, et al.. (2015). A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation. Journal of Controlled Release. 218. 29–35. 51 indexed citations

11.

Gao, Chunli, et al.. (2014). EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization andin vitroevaluation. Drug Delivery. 22(6). 785–794. 24 indexed citations

12.

Dong, Qing, Zuoxu Xie, Cao Xie, et al.. (2014). Isomeric Folate-Conjugated Polymeric Micelles Bind to Folate Receptors and Display Anticancer Effects. Asian Pacific Journal of Cancer Prevention. 15(17). 7363–7369. 5 indexed citations

13.

Li, Chong, Jie Shen, Xiaoli Wei, Cao Xie, & Weiyue Lu. (2012). Targeted delivery of a novel palmitylated D-peptide for antiglioblastoma molecular therapy. Journal of drug targeting. 20(3). 264–271. 17 indexed citations

14.

Li, Feng, Zhengji Song, Qinghua Li, et al.. (2011). Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin αvβ3 expression with SPECT in rat. Hepatology. 54(3). 1020–1030. 55 indexed citations

15.

Li, Feng, Qinghua Li, Jiyao Wang, et al.. (2011). Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor–beta on hepatic fibrosis in rats. Journal of Controlled Release. 159(2). 261–270. 64 indexed citations

16.

Yan, Zhiqiang, Fei Wang, Ziyi Wen, et al.. (2011). LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor. Journal of Controlled Release. 157(1). 118–125. 123 indexed citations

17.

Zhan, Changyou, Bing Gu, Cao Xie, et al.. (2010). Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Journal of Controlled Release. 143(1). 136–142. 317 indexed citations

18.

Wu, Zhibin, Xiangqun Li, Bryan Ericksen, et al.. (2007). Impact of Pro Segments on the Folding and Function of Human Neutrophil α-Defensins. Journal of Molecular Biology. 368(2). 537–549. 21 indexed citations

19.

Xie, Cao, Adam Prahl, Bryan Ericksen, et al.. (2005). Reconstruction of the Conserved β-Bulge in Mammalian Defensins Using d-Amino Acids. Journal of Biological Chemistry. 280(38). 32921–32929. 62 indexed citations

20.

Liu, Min, Cao Xie, Xu Wen, & Weiyue Lu. (2004). Separation of polyethylene glycols and their amino-substituted derivatives by high-performance gel filtration chromatography at low ionic strength with refractive index detection. Journal of Chromatography A. 1046(1-2). 121–126. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact